 |
 |
 |
 |
|
 | Integrated provider of sleep diagnostic services, therapy and equipment | Private | Early / 2009 |
|
 | Develops multiplexed, quantitative molecular diagnostic tests | Private | Early / 2009 |
|
 | Developing high quality, cost-effective proton therapy solutions | Private | Early / 2009 |
|
 | Disposable insulin pump for Type 2 diabetics | Private | Early / 2008 |
|
 | Percuatneous device for Lumbar Spinal Stenosis | Private | Early / 2008 |
|
 | Novel drug delivery devices for the respiratory drug market | Private | Early / 2007 |
|
 | Novel small molecule therapeutics for ophthalmic diseases | Private | Start-up / 2007 |
|
 | Develops novel molecular diagnostics with broad applications in infectious disease | Private | Start-up / 2007 |
|
 | Novel antibiotics using patented bacterial RNA targets to treat pathogens resistant to existing drugs | Private | Seed / 2006 |
|
 | Medical malpractice insurance carrier | Private | Start-up / 2006 |
|
 | Developing modified form of heparin to ameliorate cardiac ischemia-reperfusion injury following myocardial infarction | Private | Start-up / 2006 |
|
 | Specialty pharmaceuticals for dermatology based on proprietary drug delivery technologies | Private | Early / 2006 |
|
 | Institutional pharmacy serving skilled nursing facilities | Private | Early / 2005 |
|
 | Novel anti-inflammatory agents based on endogenous mediators of inflammation resolution | Private | Seed / 2005 |
|
 | Provides services to acute psychiatric patients | Private | Seed / 2004 |
|
 | Medicare Advantage healthcare provider for frail and elderly nursing facility patients | Private | Seed / 2004 |
|
 | Therapeutics that target hypoxic cells to treat cancer and benign prostatic hyperplasia | IPO 2005 | Early / 2003 |
|
 | Small molecule therapeutics for genetic disorders | IPO 2007 | Seed / 2002 |
|
 | Developer of chip-based instruments and reagents for molecular diagnostics | Acquired by Becton Dickinson, 2006 | Early / 2002 |
|
 | Catheter-based devices to treat occluded arteries | Acquired by Johnson & Johnson, 2005 | Later / 2002 |
|
 | Outpatient clinics providing primary care for veterans and indigent patients. | Private | Early / 2002 |
|
 | Developer of advanced materials, techniques and implant systems for spine surgery | Private | Start-up / 2002 |
|
 | Vaccine development | Private | Seed / 2002 |
|
 | Development and manufacture of protein microarrays | Acquired by Invitrogen Corporation, 2004 | Seed / 2001 |
|
 | Consumer focused applied genomics | IPO 2005 | Start-up / 2000 |
|
 | Pharmaceutical marketing and detailing via the Internet | Acquired by Allscripts Healthcare Solutions, 2003 | Early / 2000 |
|
 | Kidney dialysis services | Ownership stake sold to third party, 2004 | Start-up / 1999 |
|
 | Computerized systems for the analysis and prediction of clinical compounds' ADME/Tox properties | Acquired by ArQule, Inc., 2001 | Early / 1999 |
|
 | Site management organization for clinical trials of neuropsychiatric drugs | Private | Start-up / 1999 |
|
 | Drug delivery technology for localized treatment of disease | IPO 2000 | Later / 1999 |
|
 | Long-term acute care facilities | Acquired by Select Medical Corporation, 2005 | Start-up / 1999 |
|
 | Cellular and proteomics approaches to target validation for drug development | Private | Seed / 1998 |
|
 | Novel technologies for immunodiagnostics | Acquired by QIAGEN N.V., 2004 | Start-up / 1998 |
|
 | Devices to assist in the resuscitation of victims of sudden cardiac arrest | Acquired by Zoll Medical Corporation, 2004 | Early / 1998 |
|
